Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Blocker

Creative Biolabs offers our clients a comprehensive range of recombinant antibodies which are unparalleled in quality and quantity.

A blocking antibody is an antibody that does not have a reaction when combined with an antigen but prevents other antibodies from combining with that antigen. Blocking antibodies has a variety of clinical and experimental functionalities. The term can also be used for inhibiting antibody, prozone phenomenon, and agglutination reaction. Blocking antibodies have been described as a mechanism for HSV-1 to evade the immune system.

Hot Products: